This drug is used for the adjuvant treatment of intermediate and late stage lung cancer chemotherapy caused by Qi deficiency and phlegm stasis. This drug is currently the only oral preparation containing paclitaxel in the world. During the course of taking this drug, some patients may experience adverse reactions, such as gastrointestinal irritation, manifesting as nausea and vomiting, as well as mild leukopenia in the blood, and also side effects such as muscle aches and pains, etc. If the leukopenia in the blood continues to decrease, it is necessary to consider using this drug with caution.